Hafiz Talha Javed
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
Also affiliated: University of Arkansas Medical Center (2026); Medical Center of South Arkansas (2026)
Unknown Researcher
Research Areas
Biography and Research Information
OverviewAI-generated summary
Hafiz Talha Javed's research focuses on the synthesis and application of systematic reviews and meta-analyses to evaluate therapeutic interventions and diagnostic tools in various medical fields. His recent work includes a meta-analysis comparing Viz.ai and Rapid AI for stroke detection, and another examining Bruton’s tyrosine kinase (BTK) inhibitors for multiple sclerosis. He has also investigated neuroprotective agents for acute ischemic stroke patients undergoing endovascular treatment and analyzed IDH-targeted agents for lower-grade gliomas. Javed has a total of five publications and collaborates with researchers from the University of Arkansas at Little Rock and the University of Arkansas for Medical Sciences.
Metrics
- Publications: 6
Selected Publications
-
Beyond the Typical Atypical Imaging Features of Leptomeningeal Enhancement: A Case Series (2026)
-
Catch More or Call Fewer? A Systematic Review and Meta-analysis comparing Viz.ai vs Rapid AI (P6-4.018) (2026)
-
Targeting B-cell Signaling in Multiple Sclerosis: A Meta-analysis of Bruton’s Tyrosine Kinase (BTK) Inhibitors (P4-18.001) (2026)
-
Evaluation of Neuroprotective Agents In Acute Ischemic Stroke Patients Undergoing Endovascular Treatment: A Systematic Review and Meta-analysis (P7-4.016) (2026)
-
Beyond Cytotoxic Therapy: A Meta-analysis of IDH-targeted Agents in Lower-grade Gliomas (P10-6.007) (2026)
Collaboration Network
Top Collaborators
- Beyond Cytotoxic Therapy: A Meta-analysis of IDH-targeted Agents in Lower-grade Gliomas (P10-6.007)
- Evaluation of Neuroprotective Agents In Acute Ischemic Stroke Patients Undergoing Endovascular Treatment: A Systematic Review and Meta-analysis (P7-4.016)
- Targeting B-cell Signaling in Multiple Sclerosis: A Meta-analysis of Bruton’s Tyrosine Kinase (BTK) Inhibitors (P4-18.001)
- Catch More or Call Fewer? A Systematic Review and Meta-analysis comparing Viz.ai vs Rapid AI (P6-4.018)
- Beyond Cytotoxic Therapy: A Meta-analysis of IDH-targeted Agents in Lower-grade Gliomas (P10-6.007)
- Evaluation of Neuroprotective Agents In Acute Ischemic Stroke Patients Undergoing Endovascular Treatment: A Systematic Review and Meta-analysis (P7-4.016)
- Targeting B-cell Signaling in Multiple Sclerosis: A Meta-analysis of Bruton’s Tyrosine Kinase (BTK) Inhibitors (P4-18.001)
- Catch More or Call Fewer? A Systematic Review and Meta-analysis comparing Viz.ai vs Rapid AI (P6-4.018)
- Beyond Cytotoxic Therapy: A Meta-analysis of IDH-targeted Agents in Lower-grade Gliomas (P10-6.007)
- Evaluation of Neuroprotective Agents In Acute Ischemic Stroke Patients Undergoing Endovascular Treatment: A Systematic Review and Meta-analysis (P7-4.016)
- Targeting B-cell Signaling in Multiple Sclerosis: A Meta-analysis of Bruton’s Tyrosine Kinase (BTK) Inhibitors (P4-18.001)
- Beyond Cytotoxic Therapy: A Meta-analysis of IDH-targeted Agents in Lower-grade Gliomas (P10-6.007)
- Targeting B-cell Signaling in Multiple Sclerosis: A Meta-analysis of Bruton’s Tyrosine Kinase (BTK) Inhibitors (P4-18.001)
- Catch More or Call Fewer? A Systematic Review and Meta-analysis comparing Viz.ai vs Rapid AI (P6-4.018)
- Beyond Cytotoxic Therapy: A Meta-analysis of IDH-targeted Agents in Lower-grade Gliomas (P10-6.007)
- Evaluation of Neuroprotective Agents In Acute Ischemic Stroke Patients Undergoing Endovascular Treatment: A Systematic Review and Meta-analysis (P7-4.016)
- Targeting B-cell Signaling in Multiple Sclerosis: A Meta-analysis of Bruton’s Tyrosine Kinase (BTK) Inhibitors (P4-18.001)
- Beyond Cytotoxic Therapy: A Meta-analysis of IDH-targeted Agents in Lower-grade Gliomas (P10-6.007)
- Targeting B-cell Signaling in Multiple Sclerosis: A Meta-analysis of Bruton’s Tyrosine Kinase (BTK) Inhibitors (P4-18.001)
- Beyond Cytotoxic Therapy: A Meta-analysis of IDH-targeted Agents in Lower-grade Gliomas (P10-6.007)
- Targeting B-cell Signaling in Multiple Sclerosis: A Meta-analysis of Bruton’s Tyrosine Kinase (BTK) Inhibitors (P4-18.001)
- Beyond Cytotoxic Therapy: A Meta-analysis of IDH-targeted Agents in Lower-grade Gliomas (P10-6.007)
- Targeting B-cell Signaling in Multiple Sclerosis: A Meta-analysis of Bruton’s Tyrosine Kinase (BTK) Inhibitors (P4-18.001)
- Beyond Cytotoxic Therapy: A Meta-analysis of IDH-targeted Agents in Lower-grade Gliomas (P10-6.007)
- Targeting B-cell Signaling in Multiple Sclerosis: A Meta-analysis of Bruton’s Tyrosine Kinase (BTK) Inhibitors (P4-18.001)
- Evaluation of Neuroprotective Agents In Acute Ischemic Stroke Patients Undergoing Endovascular Treatment: A Systematic Review and Meta-analysis (P7-4.016)
- Catch More or Call Fewer? A Systematic Review and Meta-analysis comparing Viz.ai vs Rapid AI (P6-4.018)
- Evaluation of Neuroprotective Agents In Acute Ischemic Stroke Patients Undergoing Endovascular Treatment: A Systematic Review and Meta-analysis (P7-4.016)
- Catch More or Call Fewer? A Systematic Review and Meta-analysis comparing Viz.ai vs Rapid AI (P6-4.018)
- Beyond Cytotoxic Therapy: A Meta-analysis of IDH-targeted Agents in Lower-grade Gliomas (P10-6.007)
- Evaluation of Neuroprotective Agents In Acute Ischemic Stroke Patients Undergoing Endovascular Treatment: A Systematic Review and Meta-analysis (P7-4.016)
- Evaluation of Neuroprotective Agents In Acute Ischemic Stroke Patients Undergoing Endovascular Treatment: A Systematic Review and Meta-analysis (P7-4.016)
- Evaluation of Neuroprotective Agents In Acute Ischemic Stroke Patients Undergoing Endovascular Treatment: A Systematic Review and Meta-analysis (P7-4.016)
Similar Researchers
Based on overlapping research topics